Drreddys Laboratories | RDY - Ebit


Drreddys Laboratories reported INR3.05B in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
ANI Pharmaceuticals USD 38.71M 9.58M Mar/2026
Aurora Cannabis CAD 7.12M 42.91M Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Canopy Growth CAD -145.65M 132.99M Mar/2026
Cipla INR 6.14B 3.63B Mar/2026
Corcept Therapeutics USD -49.6M 54.09M Mar/2026
Drreddys Laboratories INR 3.05B 13.32B Mar/2026
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Lonza CHF 673M 54M Jun/2025
Novartis USD 4.18B 118M Mar/2026
Pacira USD 4.62M 1.43M Mar/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 75.49M 7M Mar/2026
Richter Gedeon HUF 62.32B 1.26B Mar/2026
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
Supernus Pharmaceuticals USD -35.25M 49.07M Mar/2026
Teva Pharmaceutical Industries USD 758M 181M Mar/2026